E
Arrowhead Pharmaceuticals, Inc. ARWR
$21.33 $0.582.80% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 27.77M 542.71M 2.50M 0.00 --
Total Other Revenue -- -- -- -- --
Total Revenue 27.77M 542.71M 2.50M 0.00 --
Cost of Revenue -- -- -- -- --
Gross Profit 27.77M 542.71M 2.50M 0.00 --
SG&A Expenses 37.41M 36.09M 30.71M 32.56M 30.84M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 193.32M 161.51M 163.91M 162.20M 176.14M
Operating Income -165.55M 381.20M -161.41M -162.20M -176.14M
Income Before Tax -179.09M 369.62M -175.12M -172.80M -173.98M
Income Tax Expenses -437.00K 1.75M 103.00K 546.00K --
Earnings from Continuing Operations -178.65M 367.86M -175.22M -173.34M -173.98M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings 3.41M 2.58M 2.13M 2.81M 3.18M
Net Income -175.24M 370.45M -173.09M -170.54M -170.79M
EBIT -165.55M 381.20M -161.41M -162.20M -176.14M
EBITDA -159.33M 387.29M -156.18M -157.18M -171.36M
EPS Basic -1.26 2.78 -1.39 -1.37 -1.38
Normalized Basic EPS -0.78 1.75 -0.86 -0.85 -0.85
EPS Diluted -1.26 2.75 -1.39 -1.37 -1.38
Normalized Diluted EPS -0.78 1.74 -0.86 -0.85 -0.85
Average Basic Shares Outstanding 139.04M 133.36M 124.85M 124.36M 124.20M
Average Diluted Shares Outstanding 139.04M 134.48M 124.85M 124.36M 124.20M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --